References
- Shields AF, Graham MM, Spence AM. The role ofPET imaging in clinical oncology. A current statusreport. In: Freeman LM, editor. Nuclear MedicineAnnual. New York: Raven Press; 1995. p. 129-68.
- Stocklin GL. Is there a future for clinicalfluorine-I8 radiopharrnaceuticals (excluding PDG)?Eur J Nucl Med 1998;25:1612-6.
- Varagnolo L, Stokkel MPM, Mazzi U, PauwelsEKJ. ISP_Iabeled radiopharmaceuticals for PET inoncology, excluding PDG. Nucl Med Bioi 2000;27:103-12.
- Ido T, Wan CN, Casella V, Fowler IS, Wolf AP,Reivich M, et al. Labeled 2-deoxy-2-gluocseanalogs. ISF-Iabeled 2-deoxy-2-fluoro-D-glucose,2-deoxy-2-fluoro-D-mannose and 14C-2-deoxy-2-fluoroD-glucose. J Labelled Cpd Radiopharm1978;14:178-83.
- Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2_[ISp] fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic fluorination. Appl Radiat [sot 1986;37:235-8.
- Koh WJ, Rasey JS, Evans ML, Grierson JR,Lewellen TK, Graham MM, et al. Imaing ofhypoxia in human tumors withC8P]fluoromisonidazole. Int J Radiat Oneal BioiPhys 1992;22:199-212.
- Tewson TJ. Synthesis of C8F]fluoroetanidazole: apotential new tracer for imaging hypoxia. Nucl MedBioi 1997;24:755-60.
- Coenen HH, Kling P, Stocklin G. Cerebralmetabolism of L-[2-18F]fluorotyrosine, a new PETtracer of protein synthesis. J Nucl Med 1989;30:1367-72.
- Tomiyoshi K, Amed K, Muhammad S, Higuchi T,Inoue T, Endo K, et al. Synthesis of isomers of18P-Iabelled amino acid radiopharmaceutical:position 2- and 3-L-18P-alpha-methyltyrosine usinga separation and purification system. Nucl MedCornrnun 1997;18:169-75.
- Wester. HJ, Herz M, Weber W, Heiss P,Senekowitsch-Schmidtke R, Schwaiger M, et al.Synthesis and radiophanrncology of 0-(2-Cl}]flucroethyl)L-tyrosine for tumor imaging. J Nucl Med1999;40:205-12.
- Comar D, Cartron JC, Maziere M, Marazano C.Labelling and metabolism of methionine-methyl-I'C.Eur J Nucl Med 1976;1:11-4.
- Langstrom B, Lundqvist H. The preparation ofllC-methyl iodide and its use in the synthesis ofllC-methyl-L-methionine. Int J Appl Radiat [sot1976;27:357-63.
- Shoup TM, Olson J, Hoffman JM, Votaw J,Eshima D, Eshima L, et al. Synthesis andevaluation of C8F]l-amino-3-fluorocyclobutane-lcarboxylicacid to image brain tumors. J Nucl Med1999;40:331-8.
- Conti PS, Alauddin MM, Fissekis JR, Schmall B,Watanabe KA. Synthesis of 2'-fluoro-5-C1C]-methyll-bera-Dvarabinofuranosyluracil ([llC]-FMAU): apotential nucleoside analog for in vivo study of cellular proliferation with PET. Nucl Med Bioi1995;22:783-9.
- Grierson JR, Shields AP, Eary JF. Development ofradiosynthesis for 3' -[P-18]fluoro-3' -deoxynucleosides.J Labelled Cpd Radiopharrn 1997;40:60-2.
- Shields AP, Grierson JR, Dohmen BM, MachullaH-J, Stayanoff JC, Lawhorn-Crews JM, et al.Imaging proliferation in vivo with [P-18]PLT andposition emission tomography. Nat Med 1998;4:1334-6.
- Katzenellenbogen JA, Welch MJ, Dehdashti F. Thedevelopment of estrogen and progestinradiopharmaceuticals for imaging breast cancer.Anticancer Res 1997;17:1573~6.
- Kiesewetter DO, Kilbourn MR, Landvatter SW,Heiman DP, Katzenellenbogen JA, Welch MJ.Preparation of four fluorine-18-labeled estrogensand their selective uptakes in target tissues ofimmature rats. J Nucl Med 1984;25:1212-21.
- Lim JL, Zheng L, Berridge MS, Tewson TJ. Theuse of 3-methoxymethyl-16P,17p-epiestriol-O-cyclicsulfone as the precursor in the synthesis of P-18 16a-fluoroestradiol. Nucl Med Bioi 1996;23:911-5.
- Romer J, Steinbach J, Kasch H. Studies on thesynthesis of 16 a-C8P]fluoroestradiol. Appl Radiat[sot 1996;47:395-9.
- Hostetler ED, Jonson SD, Welch MJ,Katzenellenbogen JA. 2-[P-18]fluoroestradiol: areceptor-based radiopharmaceutical with highbinding for SHBG. J Nucl Med 1998;39S:35P.
- Pomper MG, Katzenellenbogen JA, Welch MJ,Brodack JW, Mathias CJ. 21-C8P]Fluoro-16a-ethyl-19-norprogesterone: synthesis and targettissue selective uptake of a progestin receptor basedradiotracer for Positron Emission Tomography. JMed Chern 1988;31:1360-3.
- Kochanny MJ, VanBrocklin HP, Kym PR, CarlsonKE, O'Neil JP, Bonasera TA, et al.Fluorine-18-labeled progestin ketals: synthesis andtarget tissue uptake selectivity of potential imagingagents for receptor-positive breast tumors. J MedChern 1993;36:1120-7.
- Buckman BO, Bonasera TA, Kirschbaum KS,Welch MJ, Katzenellenbogen JA. Fluorine-18labeledprogestin 16 a,17 a-dioxolanes: developmentof high-affinity ligands for the progesteronereceptor with high in vivo target site selectivity. JMed Chern 1995;38:328-37.
- Carlson KE, Katzenellenbogen JA. A comparativestudy of the selectivity and efficiency of targettissue uptake of five tritium-labeled androgens inthe rat. J Steroid Biochern 1990;36:549-61.
- Liu A, Carlson KE, Katzenellenbogen JA. Synthesisof high affinity fluorine-substituted ligands for theandrogen receptor. Potential agents for imagingprostatic cancer by positron emission tomography. JMed Chern 1992;35:2113-29.
- Choe YS, Lidstrom PJ, Chi DY, Bonasera TA,Welch MJ, Katzenellenbogen JA. Synthesis of 11 /3_[18Flfluoro-5 a-dihydrotestosterone and 11 /3- [18Fl fluoro-19-nor-5 a -dihydrotestosterone:preparation via halofluorination-reduction, receptorbinding and tissue distribution. J Med Chern1995;38:816-25.
- Bonasera TA, O'Neil JP, Xu M, Dobkin JA, CutlerPD, Lich LL, et al. Preclinical evaluation offluorine-18-labeled androgen receptor ligands inbaboons. J Nucl Med 1996;37:1009-15.
- Eigtved A, Jensen M, Holm S, Foder B, Larsen P,Hoejgaard L, et al. [F-18lFluoro-5 a-dihydrotestosterone as a PET ligand for androgenreceptors in prostate cancer. J Nucl Med1999;40S:256P.
- Shiue CY, Bai LQ, Shiue GG, Rysavy JA, PleusRC, Hui H, et al. Synthesis of (+/-)-C8FlBMY14802, its enantiomers and their anatomical distributionsin rodents. Nucl Med Bioi 1993;20:625-30.
- Collier TL, O'Brien JC, Waterhouse RN. Synthesisof [18F] 1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine: a potential sigma-I receptor radioligandfor PET. J Labelled Cpd Radiopharrn 1996;38:78594
- Kawamura K, Ishiwata K, Tajima H, Ishii S-I, Matsuno K, Homma Y, et al. In vivo evaluation of [11C]SA4503 as a PET ligand for mapping CNS Sigma1 receptors. Nucl Med Bioi 2000;27:255-61.
- Wester H-J, Hamacher K, Stocklin G. Acomparative study of N.C.A. fluorine-18 labelingodf proteins via acylation and photochemicalconjugation. Nucl Med Bioi 1996;23:365-72.
- Guhlke S, Wester HJ, Bruns C, Stocklin G.(2C8F]Fluoropropionyl-(D)phel)-octreotide, a potentialradiopharmaceutical for quantitative somatostatinreceptor imaging with PET: synthesis, radiolabeling,in vitro validation and biodistribution in mice. NuclMed Bioi 1994;21:819-25.
- Dimitrakopoulou A, Strass LG, Clorius JH,Ostertag H, Schlag P, Heim M, et al. Studies withPET after systematic administration of fluorine-18uracilin patients with liver metastases fromcolorectal carcinoma. J Nucl Med 1993;34:1075-81.
- Oberdorfer F, Hofmann E, Maier-Brost W.Preparation of 18F-labeled 5-fluorouracil of veryhigh purity. J Labelled Cpd Radiopharm 1989;30:543-9.
- Tyler JL, Yamamoto YL, Diksic M, Theron J,Villemure JG, Worthington C, et aLPharmacokinetics of superselective intra-arterial andintravenous [11C]BCNU evaluated by PET. J NuclMed 1986;27:775-80.
- Ginos JZ, Cooper AJL, Dhawan V, Lai JCK,Strother SC, Alcock N, et al. C3N1Cisplatin PET toassess pharmacokinetics of intra-arterial versusintravenous chemotherapy for malignant braintumors. J Nucl Med 1987;28:1844-52.
- Kiesewetter DO, Eckelman WC. Radiochemicalsynthesis of C8Flfluoropaclitaxel (C8FlFPAC). JLabelled Cpd Radiopharrn 2001;44:S903-5.
- Kurdziel KA, Kiesewetter DO, Carson RE,Eckelman WC, Herscovitch P. Biodistribution,radiation dose estimates and PGP modulationstudies of 18Fpaclitaxel. J Nucl Med 2001;42S:279P.
- Yang D, Kuang LR, Cherif A, Tansey W, Li C,Lin WJ, et al. Synthesis of C8Flfluoroalanine and[18Flfluorotamoxifen for imaging breast tumors. J Drug Target 1993;1:259-67.
- Inoue T, Kim EE, Wallace S, Yang DJ, Wong FC,Bassa P, et al. Positron emission tomography usingeSF]fluorotamoxifen to evaluate therapeutic responsesin patients with breast cancer: preliminary study.Cancer Biotherapy Radiopharm 1996;11:235-45.
- Park BN, Choe YS, Chi DY, Choi Y, Lee KH,Kim SE, et al. Synthesis of 2-[methyl-11qmethoxyestradiol for in vivo studies of tumorangiogenesis. J Labelled Cpd Radiopharm 1999;42:S432-3.
- Brady F, Luthra SK, Brown G, Osman S, HarteRJA, Denny WA, et al. Carbon-l l labelling of theantitumor agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and determination ofplasma metabolites in man. Appl. Radiat. Isot.1997;48:487-92.
- Barrio JR, Namavari M, Srinivasan A, Gambit S,Cherry S, Herschman H, et al. Carbon-8radiofluorination of purines; a general approach toprobe design for gene therapy in humans. JLabelled Cpd Radiopharm 1997;40:S348.
- Alauddin MM, Conti PS, Mazza SM, Harnzeh PM,Lever JR. 9-[(3-esF]-Fluoro-l-hydroxy-2-propoxy)methyl]guanine ([lsF]_FHPG): a potential imagingagent of viral infection and gene therapy usingPET. Nucl Med Bioi 1996;23:787-92.